Literature DB >> 72471

HLA antigens in Graves' disease.

K Bech, B Lumholtz, J Nerup, M Thomsen, P Platz, L P Ryder, A Svejgaard, K Siersbaek-Nielsen, J M Hansen, J H Larsen.   

Abstract

HLA typing of 86 patients with Graves' disease was performed for the A, B, C and D series antigens. An increased frequency of HLA-B8 (47 per cent) and Dw3 (51 per cent) compared with controls (23.7 and 21 per cent, respectively) was observed. The increase of B8 and Dw3 was almost exclusively found in a group of 48 patients with relapse of disease, whereas the frequency of B8 and Dw3 in patients without relapse did not differ significantly from that of the control group. No association with the presence of exophthalmos, thyroid antibodies, or antibodies to Yersinia enterocolitica serotype 3 could be found.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 72471     DOI: 10.1530/acta.0.0860510

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  22 in total

1.  TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism.

Authors:  G Schernthaner; H Ludwig; H Schleusener; R Finke; P Kotulla; W R Mayr
Journal:  Experientia       Date:  1979-10-15

2.  Immunogenetic markers in patients with Graves' disease.

Authors:  E Schifferdecker; P Kühnl; K Schöffling; B Manfras; G Holzberger; W Spielmann; B O Böhm
Journal:  Klin Wochenschr       Date:  1991-04-04

Review 3.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

4.  Relative predispositional effects (RPEs) of marker alleles with disease: HLA-DR alleles and Graves disease.

Authors:  H Payami; S Joe; N R Farid; V Stenszky; S H Chan; P P Yeo; J S Cheah; G Thomson
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

Review 5.  Genetics of autoimmune endocrine diseases.

Authors:  J F Bach; S Caillat-Zucman
Journal:  Springer Semin Immunopathol       Date:  1993

6.  Graves' disease and thyroid associated ophthalmopathy triggered by 131I treatment of non-toxic goiter.

Authors:  B Nygaard; R A Metcalfe; J Phipps; A P Weetman; L Hegedüs
Journal:  J Endocrinol Invest       Date:  1999-06       Impact factor: 4.256

7.  HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.

Authors:  R van der Gaag; W M Wiersinga; L Koornneef; M P Mourits; M F Prummel; A Berghout; R R de Vries; G M Schreuder; J D'Amaro
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

8.  Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.

Authors:  Roberto Vita; Daniela Lapa; Francesco Trimarchi; Giuseppe Vita; Poupak Fallahi; Alessandro Antonelli; Salvatore Benvenga
Journal:  Endocrine       Date:  2016-03-07       Impact factor: 3.633

9.  Graves' disease: immunological and immunogenetic indicators of relapse.

Authors:  T W de Bruin; J H Bolk; J K Bussemaker; T Stijnen; G M Schreuder; R R de Vries; D van der Heide
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

Review 10.  Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment.

Authors:  Francesca Pastore; Antonio Martocchia; Manuela Stefanelli; Pietro Prunas; Stefania Giordano; Lavinia Toussan; Antonio Devito; Paolo Falaschi
Journal:  World J Hepatol       Date:  2016-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.